| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.02 |